JUL 24, 2018 10:45 AM PDT

Transfection, Transduction, and CRISPR...Oh My

Genetic engineering is not new, however new advances are creating opportunity and reservation amongst those in the scientific community.

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats and is one of the most considerable scientific findings of recent years.  It is based on the mechanism of bacterial transformation.  This process is part of a bacterium’s immune system and is used for gene transfer which allows bacteria to adapt to their environment by incorporating exogenous genetic material into their genome. 

Transfection, a related term, is used when bacteria are used to insert new genetic material into nonbacterial cells (animals or plants).  The term “transformation” is not used in this instance because it is already used to relay information about the progression of cancer.  The DNA in question is called a plasmid during this process.  Only certain strains are capable of taking up new external DNA in a laboratory setting.  In nature, it is likely that more bacteria are able to utilize this unique feature of their immune system. Transformation was reportedly discovered in 1928 in Streptococcus pneumonia colonies by bacteriologist Frederick Griffith in England. 

Transduction is the term used to describe when DNA is transferred from bacteria to bacteria via a virus.  In this instance, the new DNA is inserted into the bacteria through the use of a viral vector.  This mechanism is of clinical value because it is a method widely believed to be how antibiotic drugs become ineffective; viruses transfer antibiotic resistant genes between bacteria.

CRISPR (pronounced “crisper”) provides opportunities for site-specific modification of the genome without the use of bacteria to transfect new DNA into an animal cell line.  CRISPR protocols can use a single guide RNA (sgRNA) which is defined by the researcher and is specific for a DNA region where binding should occur.  The other functional element needed is an RNA guided DNA endonuclease enzyme (most commonly used and researched is CRISPR associated protein 9, or Cas9) to cut double stranded DNA to allow the new genetic material to be inserted.  Cas9 is the endonuclease associated with the adaptive immunity of Streptococcus pyogenes.  It is reportedly simple to use and requires less steps than traditional transfection with bacteria.

The literature reports that the DNA repair results in insertions or deletions (indels) of very small amounts of DNA (<20 base pairs) in addition to the target gene; this is how immunotherapy models are being created for clinical oncology use.  Based on this, the conclusion has been that Cas9 use with CRISPR is specific and clinical trials using cells edited by CRISPR-Cas9 have been initiated.  In separate studies, researchers have found that in rare instances larger sections of DNA can be deleted in “off-target” regions of the genome in mouse models.

The result of these potential larger sections being deleted is the potential production of a pathogenic state; the physical loss of alleles/genes (deletion) can lead to cancer and other potential disease states. 

The technology and ability still remain an amazing feat of scientific ingenuity using the bacterial model as a guide; however, there are still dangers and ethical concerns regarding the editing of genes which should be included in future conversations about the potential of this capability.

Sources: Nature Biotechnology, Lumen, An Introduction to Genetic Analysis, 7th Ed., Journal of Visualized Experiments,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
AUG 07, 2018
Cancer
AUG 07, 2018
Can a Myeloid Marker Be Helpful in B-cell Neoplasm Diagnostic Testing?
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detailed diagnosis....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
SEP 15, 2018
Clinical & Molecular DX
SEP 15, 2018
Cancer & Anoikis: A Match Not Made in Heaven
Anoikis have always been intimately entwined with cancer, henceforth the quest to seek how they came to be as such....
OCT 06, 2018
Genetics & Genomics
OCT 06, 2018
Genetic Mutation Linked to Increased Pancreatic Cancer Risk in Women
In a first, researchers have found a genetic mutation that has a sex-specific effect on pancreatic cancer risk....
DEC 11, 2018
Cancer
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
Loading Comments...